Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.

de Camargo TM, de Freitas EO, Gimenez AM, Lima LC, de Almeida Caramico K, Françoso KS, Bruna-Romero O, Andolina C, Nosten F, Rénia L, Ertl HCJ, Nussenzweig RS, Nussenzweig V, Rodrigues MM, Reyes-Sandoval A, Soares IS.

Sci Rep. 2018 Jan 18;8(1):1118. doi: 10.1038/s41598-017-19063-6.

PMID:
29348479
2.

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.

Cabral-Miranda G, Heath MD, Gomes AC, Mohsen MO, Montoya-Diaz E, Salman AM, Atcheson E, Skinner MA, Kramer MF, Reyes-Sandoval A, Bachmann MF.

Vaccines (Basel). 2017 Sep 27;5(4). pii: E32. doi: 10.3390/vaccines5040032.

3.

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A, S Rollier C, Tang CK, Longley R, Hill AVS, Reyes-Sandoval A.

Sci Rep. 2017 Aug 4;7(1):7284. doi: 10.1038/s41598-017-07246-0.

4.

Current trends in Zika vaccine development.

Lagunas-Rangel FA, Viveros-Sandoval ME, Reyes-Sandoval A.

J Virus Erad. 2017 Jul 1;3(3):124-127.

5.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA, Kramer MF, Bachmann MF.

Vaccines (Basel). 2017 May 2;5(2). pii: E10. doi: 10.3390/vaccines5020010.

6.

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.

Salman AM, Montoya-Díaz E, West H, Lall A, Atcheson E, Lopez-Camacho C, Ramesar J, Bauza K, Collins KA, Brod F, Reis F, Pappas L, González-Cerón L, Janse CJ, Hill AVS, Khan SM, Reyes-Sandoval A.

Sci Rep. 2017 Apr 18;7:46482. doi: 10.1038/srep46482.

7.

Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.

Rodrigues-da-Silva RN, Soares IF, Lopez-Camacho C, Martins da Silva JH, Perce-da-Silva DS, Têva A, Ramos Franco AM, Pinheiro FG, Chaves LB, Pratt-Riccio LR, Reyes-Sandoval A, Banic DM, Lima-Junior JD.

Front Immunol. 2017 Feb 7;8:77. doi: 10.3389/fimmu.2017.00077. eCollection 2017.

8.

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.

Alves E, Salman AM, Leoratti F, Lopez-Camacho C, Viveros-Sandoval ME, Lall A, El-Turabi A, Bachmann MF, Hill AV, Janse CJ, Khan SM, Reyes-Sandoval A.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00501-16. doi: 10.1128/CVI.00501-16. Print 2017 Apr.

9.

Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria.

Cardoso AR, Cabral-Miranda G, Reyes-Sandoval A, Bachmann MF, Sales MGF.

Biosens Bioelectron. 2017 May 15;91:833-841. doi: 10.1016/j.bios.2017.01.031. Epub 2017 Jan 15.

PMID:
28157657
10.

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.

Rollier CS, Hill AVS, Reyes-Sandoval A.

Vaccine. 2016 Aug 31;34(38):4470-4474. doi: 10.1016/j.vaccine.2016.07.050. Epub 2016 Jul 30.

11.

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.

Daniels-Treffandier H, de Nie K, Marsay L, Dold C, Sadarangani M, Reyes-Sandoval A, Langford PR, Wyllie D, Hill F, Pollard AJ, Rollier CS.

PLoS One. 2016 Feb 12;11(2):e0148840. doi: 10.1371/journal.pone.0148840. eCollection 2016.

12.

Tailoring a Combination Preerythrocytic Malaria Vaccine.

Bauza K, Atcheson E, Malinauskas T, Blagborough AM, Reyes-Sandoval A.

Infect Immun. 2015 Dec 14;84(3):622-34. doi: 10.1128/IAI.01063-15.

13.

Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.

Longley RJ, Reyes-Sandoval A, Montoya-Díaz E, Dunachie S, Kumpitak C, Nguitragool W, Mueller I, Sattabongkot J.

Clin Vaccine Immunol. 2015 Dec 9;23(2):117-24. doi: 10.1128/CVI.00501-15.

14.

Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen.

Clutton G, Bridgeman A, Reyes-Sandoval A, Hanke T, Dorrell L.

Hum Vaccin Immunother. 2015;11(4):1030-5. doi: 10.1080/21645515.2015.1009809.

15.

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, Hill AV, Reyes-Sandoval A.

Infect Immun. 2014 Mar;82(3):1277-86. doi: 10.1128/IAI.01187-13. Epub 2013 Dec 30.

16.

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC.

Virol J. 2013 Dec 5;10:349. doi: 10.1186/1743-422X-10-349.

17.

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.

Ewer KJ, O'Hara GA, Duncan CJ, Collins KA, Sheehy SH, Reyes-Sandoval A, Goodman AL, Edwards NJ, Elias SC, Halstead FD, Longley RJ, Rowland R, Poulton ID, Draper SJ, Blagborough AM, Berrie E, Moyle S, Williams N, Siani L, Folgori A, Colloca S, Sinden RE, Lawrie AM, Cortese R, Gilbert SC, Nicosia A, Hill AV.

Nat Commun. 2013;4:2836. doi: 10.1038/ncomms3836.

18.

Plasmodium vivax malaria vaccines: why are we where we are?

Reyes-Sandoval A, Bachmann MF.

Hum Vaccin Immunother. 2013 Dec;9(12):2558-65. doi: 10.4161/hv.26157. Epub 2013 Aug 26. Review.

19.

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.

White AD, Sibley L, Dennis MJ, Gooch K, Betts G, Edwards N, Reyes-Sandoval A, Carroll MW, Williams A, Marsh PD, McShane H, Sharpe SA.

Clin Vaccine Immunol. 2013 May;20(5):663-72. doi: 10.1128/CVI.00690-12. Epub 2013 Feb 27.

20.

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

Betts G, Poyntz H, Stylianou E, Reyes-Sandoval A, Cottingham M, Hill A, McShane H.

PLoS One. 2012;7(12):e50447. doi: 10.1371/journal.pone.0050447. Epub 2012 Dec 21.

Supplemental Content

Loading ...
Support Center